Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

HearAtLast To Launch Exclusive Groundbreaking Neuro-CompensatorTM Technology Hearing Aids From VitaSound
HearAtLast Holdings, Inc. (PINKSHEETS: HRAL), a leading provider of suitable affordable solutions to clients with hearing needs in the billion dollar hearing loss market, announced that in keeping with its tradition of bringing innovative new products to consumers, the Company announces the unveiling of breakthrough hearing products based on the Neuro-Compensator™ algorithm technology from VitaSound Audio.

Complaints Of Fatigue And Tiredness In People With OSA Improve With CPAP Treatment
A study in the June 15 issue of the Journal of Clinical Sleep Medicine shows that the complaints of fatigue and tiredness in patients with obstructive sleep apnea (OSA) improved significantly with good adherence to continuous positive airway pressure (CPAP) therapy, suggesting that - like the symptom of excessive daytime sleepiness - these complaints are important symptoms of OSA.
News of the day
Value Of Genetic Testing For Preventing Blood Clots Unproven, According To New AHRQ Study
According to a new report by HHS" Agency for Healthcare Research and Quality, there is insufficient evidence to conclude that genetic testing for two gene mutations in adults with a history of blood clots helps to prevent a condition known as deep-vein thrombosis or to improve other clinical outcomes.
Health Insurance

The Very First All Spanish "Surgery Robot" Is Now Operating In Malaga

The routine use of this first commercial robot assistant culminates the process of investigation, development, technology transfer and the marketing of this robot. Four years ago the Spanish company SENER became interested in the ongoing research by the Medical Robotics Group of the University of Malaga. They were developing a robot-assistant prototype designed especially for minimally invasive surgery. This robot was to be voice controlled and able to move the endoscope with the total precision required in these types of procedures. It was in 2004 that this prototype was first put to the test in surgical procedures performed on human patients, and its benefits were quickly verified: freeing the surgeon of the habitual fatigue caused by the deep concentration need in such procedures, and consequently reducing the amount of time of the operation. It is worthy mentioning that this laparoscopic robot is the very first one to have been exclusively developed by Spanish scientists. Once the company SENER showed their interest it didn"t take long before the robot was patented, and its novel concept was endorsed by the Spanish Office of Patents & Trademarks and the European Patent Office; there does not exist another patent similar to this system that has the adroitness to control the robot"s movements. Since UMA"s robot has been patented in Spain, patent rights have been extended to the EU, The United States and Japan, granting those licence rights exclusively to SENER. This company has industrialized the prototype that has been designed and developed by the Group of Medical Robotics of the UMA, and in turn have produced it into a commercial product. This has been a complex task, in which the researchers have also been involved by giving the company that personal in-depth knowledge that can not be acquired by the patent alone. This has all resulted in a very satisfactory outcome where all money that is invested in research is given back to society, in the form of this entirely designed and manufactured Spanish, first series, product being used in the Hospital Universitario Virgen de la Victoria in Malaga. Mç¡laga Universidad


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009